Medicare Enrolled
Dr. Lisa Leschek-Gelman, MD
Neurology · Abington, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Leschek-Gelman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leschek-Gelman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Leschek-Gelman
Dr. Lisa Leschek-Gelman is a neurology specialist in Abington, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Leschek-Gelman performed 1,031 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Leschek-Gelman received a total of $6,186 from 64 pharmaceutical and/or device companies across 329 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Leschek-Gelman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in PA
$6,186 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,031
Medicare services
Top 11% in PA for neurology
Not available
Unique patients (not deduplicated)
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
241 | $93 | $261 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
211 | $83 | $266 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
106 | $69 | $349 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
82 | $105 | $328 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
73 | $107 | $308 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $140 | $300 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
49 | $119 | $394 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
48 | $35 | $372 |
| New patient office visit, complex (60-74 min) | 44 | $162 | $414 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
35 | $232 | $962 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
31 | $88 | $328 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $142 | $491 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
15 | $65 | $191 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
14 | $203 | $500 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
11 | $167 | $372 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,186
Total received (2018-2024)
Avg $1,031/year across 6 years
Top 28% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
329
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$700
2023
$1,519
2022
$1,187
2021
$630
2019
$525
2018
$1,624
Payments by company (2024)
ABBVIE INC.
$254
HARMONY BIOSCIENCES LLC
$54
SK Life Science, Inc.
$54
Harmony Biosciences Llc
$40
ARGENX US, INC.
$39
JAZZ PHARMACEUTICALS INC.
$33
Lundbeck LLC
$26
Grifols USA, LLC
$24
GE HEALTHCARE
$24
Theragen, Inc.
$23
Neurelis, Inc.
$22
Merz Pharmaceuticals, LLC
$20
CSL Behring
$19
Otsuka America Pharmaceutical, Inc.
$19
Axsome Therapeutics, Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Sumitomo Pharma America, Inc.
$16
Top 3 companies account for 51.7% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,370
Alexion Pharmaceuticals, Inc.
$339
ARGENX US, INC.
$280
CSL Behring
$239
Sunovion Pharmaceuticals Inc.
$210
Genentech USA, Inc.
$204
UCB, Inc.
$182
US WorldMeds, LLC
$179
Novartis Pharmaceuticals Corporation
$164
JAZZ PHARMACEUTICALS INC.
$149
Teva Pharmaceuticals USA, Inc.
$143
E.R. Squibb & Sons, L.L.C.
$140
Acorda Therapeutics, Inc
$134
UPSHER-SMITH LABORATORIES LLC
$133
Grifols USA, LLC
$127
Janssen Pharmaceuticals, Inc
$120
SK Life Science, Inc.
$111
EMD Serono, Inc.
$108
Allergan Inc.
$102
GENZYME CORPORATION
$101
Promius Pharma LLC
$100
Celgene Corporation
$90
Sumitomo Pharma America, Inc.
$80
Mallinckrodt LLC
$71
Biohaven Pharmaceuticals, Inc.
$71
Eisai Inc.
$70
Amgen Inc.
$69
ACADIA Pharmaceuticals Inc
$66
HARMONY BIOSCIENCES LLC
$54
PFIZER INC.
$54
Lilly USA, LLC
$53
Biogen, Inc.
$53
Jazz Pharmaceuticals Inc.
$51
Merz Pharmaceuticals, LLC
$48
TG THERAPEUTICS, INC.
$46
Axsome Therapeutics, Inc.
$45
AstraZeneca Pharmaceuticals LP
$44
Harmony Biosciences Llc
$40
MDD US Operations, LLC
$34
ASSERTIO THERAPEUTICS, Inc.
$32
IMPEL PHARMACEUTICALS INC.
$32
Boston Scientific Corporation
$32
Impax Laboratories, Inc.
$28
Merck Sharp & Dohme Corporation
$27
Lundbeck LLC
$26
GE HEALTHCARE
$24
AbbVie Inc.
$23
Theragen, Inc.
$23
Upsher-Smith Laboratories LLC
$22
Neurelis, Inc.
$22
Greenwich Biosciences, Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$20
Otsuka America Pharmaceutical, Inc.
$19
Avanir Pharmaceuticals, Inc.
$19
LivaNova USA, Inc.
$18
Metacel Pharmaceuticals LLC
$16
ARBOR PHARMACEUTICALS, INC.
$16
GE HealthCare
$15
AbbVie, Inc.
$14
Neurocrine Biosciences, Inc.
$14
Harmony Biosciences LLC
$13
Corium, LLC
$13
Strongbridge US INC.
$13
Medtronic Vascular, Inc.
$11
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · ActaStim-S · Adlarity · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · Cambia · DAYBUE · DUOPA · ELIQUIS · EMGALITY · EPIDIOLEX · Epidiolex · FABRY-DISEASE · Fycompa · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Hizentra · Horizant · INBRIJA · INGREZZA · KEVEYIS · KYNMOBI · LEMTRADA · Leqembi · MAYZENT · MYOBLOC · NAMZARIC · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ozobax · PANZYGA · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Rebif · Reveal LINQ · SOLIRIS · SUNOSI · Soliris · Sunosi · TOSYMRA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
530
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
JEFFERSON ABINGTON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Leschek-Gelman is a clinical cardiology specialist, with above-average Medicare volume (top 11% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Leschek-Gelman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Leschek-Gelman performed 241 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Leschek-Gelman receive payments from pharmaceutical companies?
Yes. Dr. Leschek-Gelman received a total of $6,186 from 64 companies across 329 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leschek-Gelman's costs compare to other neurologists in Abington?
Dr. Leschek-Gelman's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leschek-Gelman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Abington
Browse neurologists in Abington ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
ARGENX US, INC. Payments to Doctors
See all physicians who received payments from ARGENX US, INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology